Kedrion Biopharma

Kedrion Biopharma is a global biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies for rare and serious conditions. Headquartered in Italy, Kedrion focuses on treating immune deficiencies, hemophilia, and other blood disorders. With a strong presence in the U.S. and international markets, the company collaborates with healthcare providers to improve patient access to life-saving treatments while advancing research in plasma-derived therapeutics.